Firalis

Firalis has the mission to create novel value via biomarker discovery, development and regulatory qualification ultimately leading to biomarker-based diagnostics. Firalis has built a leading position in biomarker development for translational applications in preclinical & clinical settings and has experience with developing and validating various biomarker assay formats including multiplexed approaches. Firalis offers an ISO17025 accredited laboratory, ISO13485 certified and ISO9001 environment and regulatory expertise that is used by initiatives in drug development projects and pharma-driven biomarker projects, and has extensive IPR and commercial expertise.